Plerixafor (Mozobil®) recommended for use within NHS Wales in combination with G-CSF

Treatment is intended to enhance mobilisation of haematopoietic stem cells (HSCs) to peripheral blood for collection and subsequent autologous transplantation in children aged ≥ 1 to <18 years with lymphoma/solid malignant tumours .

All Wales Medicines Strategy Group